CYP3A4/5 and pharmacogenetics in patients with sarcoma - Authors' reply.
University Musculoskeletal Oncology Unit and Program in Molecular Biology and Cancer, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada.
Jay S
JS
Wunder
Torsten O
TO
Nielsen
Robert G
RG
Maki
Brian
B
O'sullivan
Benjamin A
BA
Alman
D001859:Bone Neoplasms / Q000235:genetics*; D051544:Cytochrome P-450 CYP3A; D003577:Cytochrome P-450 Enzyme System / Q000235:genetics*; D005838:Genotype; D006801:Humans; D010597:Pharmacogenetics; D020641:Polymorphism, Single Nucleotide; D012509:Sarcoma / Q000235:genetics*
D003577:Cytochrome P-450 Enzyme System; C510164:CYP3A5 protein, human; D051544:Cytochrome P-450 CYP3A; C510163:CYP3A4 protein, human